Virtus ETF Advisers LLC Bristol Myers Squibb CO Transaction History

Virtus ETF Advisers LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $63,009 - $69,961	-989 Reduced 8.16%	11,124 $711,000
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $92,782 - $105,236	1,412 Added 13.2%	12,113 $839,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $95,803 - $113,444	1,399 Added 15.04%	10,701 $769,000
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $52 - $30,889	-402 Reduced 4.14%	9,302 $661,000
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $704,704 - $776,125	9,704 New	9,704 $747,000
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $65,585 - $72,676	-1,142 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$54.82 - $64.09 $39,744 - $46,465	725 Added 173.86%	1,142 $67,000
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $23,292 - $33,849	-502 Reduced 54.62%	417 $23,000
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $45,223 - $58,990	919 New	919 $59,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.